 ENGLEWOOD, Colo., May 21, 2021 PRNewswire -- Ampio Pharmaceuticals NYSE American: AMPE, a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced details on the companys poster presentation, Regulatory Decisions during COVID-19: Efficient Nonclinical Inhalation Toxicology for a Clinical Program, being given at the 23rd International Congress of the International Society for Aerosols in Medicine ISAM, in Boise, Idaho, May 22 to 26, 2021. 